top of page
.png)
THE CHALLENGE
Diabetes is growing worldwide.
So is the burden of its complications.
589M
ADULTS LIVING WITH
DIABETES WORLDWIDE
Diabetic retinopathy is a major complication of both type 1 and type 2 diabetes and an important cause of vision loss. As the global prevalence of diabetes continues to rise, so does the need for effective, less burdensome treatment options.
US$1.0T
DIABETES-RELATED
HEALTH EXPENDITURE
Source: IDF Diabetes Atlas, 11th Edition (2025)
OUR APPROACH
Targeting disease at the RNA level
TARGET
Long non-coding RNAs
SILENCE
RNA Interference (RNAi)
DELIVER
Non-invasive ocular delivery
OUR VISION
A better world when it is seen better by everyone.
SUPPORTED BY
LATEST NEWS
FOLLOW OUR JOURNEY
bottom of page